ArticleCEN case reports2025
Microscopic polyangiitis with histopathologic evolution in serial renal biopsies during treatment of idiopathic pulmonary fibrosis.
Article in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease associated with inflammation implicated in the development of vasculitis, specifically microscopic polyangiitis (MPA). Herein, we report a case of MPA complicated by IPF. A woman in her 70s with a history of IPF treated with nintedanib presented with a serum creatinine level of 2.22 mg/dL, microscopic hematuria, and a serum myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) titer level of 78.5 IU/mL. The initial renal biopsy revealed diffuse tubulointerstitial nephritis without glomerular crescent formation; therefore, prednisolone was initiated. However, the serum MPO-ANCA titer level increased to 91.1 IU/mL after tapering the prednisolone dose. A second renal biopsy revealed pauci-immune necrotizing glomerulonephritis with crescents, confirming MPA. Treatment was adjusted to include a resumed steroid regimen and combination therapy with rituximab and avacopan, resulting in stable kidney function. In conclusion, this case underscores the importance of monitoring serum ANCA titer levels as a surrogate marker for subclinical vasculitis in patients with IPF. The sequential occurrence of tubulointerstitial nephritis followed by crescentic glomerulonephritis suggests a potential progression pattern in MPA, warranting careful clinical and histopathological evaluations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.